[Safety profile of parenteral meglumine antimoniate (Glucantime ®) in infants treated for cutaneous leishmaniasis].

[Safety profile of parenteral meglumine antimoniate (Glucantime®) in infants treated for cutaneous leishmaniasis]. Therapie. 2019 May 16;: Authors: Frikha F, Boudaya S, Bahloul E, Amouri M, Turki H PMID: 31151663 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31151663?dopt=Abstract

Source: Therapie - May 15, 2019 Category: Psychiatry & Psychology Authors: Frikha F, Boudaya S, Bahloul E, Amouri M, Turki H Tags: Therapie Source Type: research

More News: Psychology